meddevicedb.com FDA Device Reference

AP-1010 AND AP-1020 BLOOD GLUCOSE MONITORING SYSTEM, MAJOR GLUCOSE CONTROL SOLUTION

K103044 Class II Traditional
Decision Date
2012-02-10
Sponsor / Applicant
Bestgen Biotech Corp.

Technical Specification

510(k) Submission ID K103044
Product Code NBW
Medical Specialty / Panel Clinical Chemistry
Regulation Citation 21 CFR 862.1345
Decision Date 2012-02-10
Clearance Pathway Traditional

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

AP-1010 AND AP-1020 BLOOD GLUCOSE MONITORING SYSTEM, MAJOR GLUCOSE CONTROL SOLUTION received FDA 510(k) clearance under submission number K103044, sponsored by Bestgen Biotech Corp.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 2012-02-10.

Classification & Regulation

This clearance is catalogued under FDA product code NBW and 21 CFR 862.1345, within the Clinical Chemistry review panel as a Class II device.